Rakuten Medical, Inc.

Recent biopharmaceutical venture capital financings reflect a worldly investment view, even at the $100m-plus mega-round level where the largest investments tend to be more frequent in the US. The six

Alkem Laboratories Ltd has launched the first-ever biosimilar cetuximab in India at a significant price differential to Merck KGaA ’s on-market Erbitux, promising to widen access to the therapy for

Since Japan introduced its "Sakigake" pioneering therapy review and approval scheme on a pilot basis in 2015, a total of 27 products have been admitted, with 11 moving through to their first approval

Since Japan introduced its "Sakigake" pioneering therapy review and approval scheme on a pilot basis in 2015, a total of 27 products have been admitted, with 11 moving through to their first approval